Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Luminex Corporation, now a key part of DiaSorin, is a biotechnology company that develops, manufactures, and markets proprietary biological testing technologies with applications in life sciences and clinical diagnostics. Renowned for its versatile xMAP® multiplexing technology, Luminex empowers laboratories worldwide to perform a wide range of assays quickly, accurately, and cost-effectively. Their solutions significantly contribute to areas such as infectious disease testing, genetic analysis, personalized medicine, and drug discovery, advancing healthcare and research on a global scale.
Serves as a primary hub for research and development of multiplexing assays and instruments, manufacturing of xMAP® microspheres and related products, and corporate operations for the Luminex segment within DiaSorin.
Features advanced R&D labs, ISO-certified manufacturing facilities for beads and instruments, and collaborative office spaces. The campus includes amenities supporting employee well-being and a focus on sustainable practices.
Fosters a culture of scientific inquiry, precision, and customer focus, integrated within DiaSorin's global commitment to innovation in diagnostics. Emphasis on cross-functional teamwork and quality in all processes.
A critical site for the innovation, development, and production of Luminex's core xMAP® technology and a wide array of diagnostic and life science research solutions. It plays a vital role in DiaSorin's molecular diagnostics and licensed technologies business.
As part of DiaSorin, Luminex Corporation has a robust global footprint, with operations, sales, and support functions spanning North America, Europe, Asia-Pacific, and Latin America. This worldwide network includes R&D centers, manufacturing sites, direct sales teams, and extensive distributor partnerships, ensuring that its innovative diagnostic and life science technologies reach customers in academic, clinical, pharmaceutical, and biotechnology laboratories across the globe.
12212 Technology Blvd
Austin
Texas
USA
Address: 1200 Bay Street, Suite 300, Toronto, ON M5R 2A5, Canada (Luminex Molecular Diagnostics site)
Supports DiaSorin's molecular diagnostics portfolio in Canada and North America, leveraging expertise in rapid diagnostic testing for clinical laboratories.
Address: Het Zuiderkruis 12, 5215 MV 's-Hertogenbosch, Netherlands
Strengthens DiaSorin's commercial presence and customer service capabilities in Europe, ensuring efficient delivery and support for Luminex technologies across the continent.
Address: Unit 06, 39F, KIC Plaza II, No.333 Songhu Road, Yangpu District, Shanghai, China
Supports the growing demand for advanced diagnostic and life science research tools in China and the broader APAC market, providing local expertise and customer engagement.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Luminex ' leadership includes:
Luminex has been backed by several prominent investors over the years, including:
Following its acquisition by DiaSorin in July 2021, Luminex's executive leadership was integrated into the DiaSorin corporate structure. The primary leadership for the Luminex segment, such as President Angelo Rago, has remained stable. No significant, publicly announced executive hires or departures specifically for the Luminex-segment top leadership have been widely reported in the last 12 months outside of broader DiaSorin corporate governance announcements.
Discover the tools Luminex uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Luminex Corporation, prior to and during its integration with DiaSorin, primarily utilized an email format combining the first initial and last name. While variations may exist, this is the most commonly observed pattern for @luminexcorp.com addresses.
[first_initial][last]@luminexcorp.com
Format
jdoe@luminexcorp.com
Example
70%
Success rate
DiaSorin S.p.A. • May 8, 2024
DiaSorin released its Q1 2024 financial results, highlighting the performance of its Licensed Technologies segment, which includes the former Luminex businesses. The report detailed revenues of €70 million for Licensed Technologies (constant exchange rates), indicating the ongoing strategic importance and market presence of Luminex's multiplexing technology in research and diagnostic fields....more
GenomeWeb • December 14, 2023
DiaSorin Molecular, leveraging technology from its Luminex acquisition, received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its Simplexa COVID-19 & Flu A/B Direct kit. This multiplex test is designed for the qualitative detection and differentiation of RNA from SARS-CoV-2, influenza A virus, and influenza B virus, enhancing diagnostic capabilities for respiratory illnesses....more
Luminex Corporation (DiaSorin) • July 25, 2023
Luminex, a DiaSorin Company, announced its participation in the American Association for Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo, showcasing its comprehensive portfolio of diagnostic solutions. This included innovations in multiplexing technology, molecular diagnostics, and flow cytometry, underscoring its commitment to advancing laboratory medicine....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Luminex , are just a search away.